BioCentury
ARTICLE | Clinical News

Avastin bevacizumab: Phase III data

June 7, 2004 7:00 AM UTC

Previously reported results from a Phase III trial in 813 patients showed that those given irinotecan, bolus fluorouracil and leucovorin (IFL) plus Avastin survived significantly longer than those giv...